• FirefoxInstall the new Firefox »
  •  Dow Down1.54% Nasdaq Down1.11%

    AVEO Pharmaceuticals, Inc. (AVEO)

    1.50 Up 0.08(5.63%) 4:00PM EST
    |After Hours : 1.54 Up 0.04 (2.67%) 7:38PM EST
    Add to Portfolio
    HeadlinesGet Headlines for:
    [audio] [audio] AVEO Oncology Biomarker Analysis from Phase 2 Clinical Study of Tivozanib in Patients with Advanced Colorectal Cancer (recorded earlier today)

    No headlines available for AVEO prior to August 24, 2013.